Brochure
24 Aug 2023

Sugammadex Sodium API article

PDF 212 kB

Sugammadex sodium is one of the key molecules in Dr. Reddy’s API portfolio and an ideal use case on how a thorough understanding of the interaction between API and formulation can significantly improve the robustness of the formulation process considering the drug substance’s proneness to degradation in the formulation process, specifically during the terminal sterilization (TS) process for intravenous injection.

Content provided by our supplier

Dr. Reddy's Laboratories SA

  • Country/Region:
    Switzerland
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Chemical Development
Generic APIs producer
Pharmaceutical Company (generic finished products)

Other Content from Dr. Reddy's Laboratories SA ()